Cargando…

A novel mutation in NLRC4 in a large pedigree with an anakinra responsive autoinflammatory disease

Detalles Bibliográficos
Autores principales:	Volker-Touw, N, de Koning, H, van Kempen, T, Oberndorff, K, van Steensel, M, Giltay, J, Boes, M, de Kovel, C, Simon, A, Frenkel, J, van Gijn, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597177/ http://dx.doi.org/10.1186/1546-0096-13-S1-P30

Ejemplares similares

Reduced serpinB9-mediated caspase-1 inhibition can contribute to autoinflammatory disease
por: van der Burgh, Robert, et al.
Publicado: (2016)

Cerebral autoinflammatory disease treated with anakinra
por: Jang, Yoonhyuk, et al.
Publicado: (2018)

Anakinra treatment for refractory cerebral autoinflammatory responses
por: Jang, Yoonhyuk, et al.
Publicado: (2022)

Recessive NLRC4-Autoinflammatory Disease Reveals an Ulcerative Colitis Locus
por: Steiner, Annemarie, et al.
Publicado: (2021)

The off-label use of anakinra in pediatric systemic autoinflammatory diseases
por: Maniscalco, Valerio, et al.
Publicado: (2020)

Mullins’ syndrome: a new gammopathy-related autoinflammatory syndrome resistant to anakinra
por: Longhurst, H.J., et al.
Publicado: (2015)

Targeted NGS based hereditary autoinflammatory disorder screening in routine diagnostics, two year experience in the Netherlands
por: Elferink, MG, et al.
Publicado: (2015)

Autoinflammatory mutation in NLRC4 reveals a leucine-rich repeat (LRR)–LRR oligomerization interface
por: Moghaddas, Fiona, et al.
Publicado: (2018)

Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined genetic cause
por: Harrison, S, et al.
Publicado: (2015)

Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes
por: Urien, Saik, et al.
Publicado: (2013)

Efficacy and safety of anakinra for undifferentiated autoinflammatory diseases in children: a retrospective case review
por: Garg, Suchika, et al.
Publicado: (2019)

Coronavirus Disease 2019 in a Patient With a Systemic Autoinflammatory Syndrome due to an NLRC4 Inflammasomopathy
por: Duncan-Lowey, Jeffrey K, et al.
Publicado: (2021)

Therapy of autoinflammatory diseases: a review of the literature
por: ter Haar, NM, et al.
Publicado: (2011)

Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network
por: Gaggiano, Carla, et al.
Publicado: (2021)

Recommendations for the management of autoinflammatory diseases
por: ter Haar, N, et al.
Publicado: (2015)

Development of the autoinflammatory disease damage index (ADDI)
por: Annink, K, et al.
Publicado: (2015)

Behçet's Syndrome in a Chinese Pedigree of NLRP3-Associated Autoinflammatory Disease: A Coexistence or Novel Presentation?
por: Liu, Jinjing, et al.
Publicado: (2021)

An Update on Autoinflammatory Diseases
por: Ciccarelli, F., et al.
Publicado: (2013)

Computing approximate monogenic model likelihoods in large pedigrees with loops
por: Janss, LLG, et al.
Publicado: (1995)

PReS-FINAL-2210: Qualitative aspects of autoinflammatory diseases
por: Konukbay, D, et al.
Publicado: (2013)

PW02-023 - Qualitative aspects of autoinflammatory diseases
por: Konukbay, D, et al.
Publicado: (2013)

Immunopathogenesis of granulomas in chronic autoinflammatory diseases
por: Timmermans, Wilhelmina Maria Cornelia, et al.
Publicado: (2016)

Gene expression in large pedigrees: analytic approaches
por: Cantor, Rita M., et al.
Publicado: (2016)

In silico validation of the Autoinflammatory Disease Damage Index
por: ter Haar, Nienke M, et al.
Publicado: (2018)

Diagnostic value of urinary mevalonic acid excretion in patietns with a clinical suspicion of mevalonate kinase deficiency (MKD)
por: Jeyaratnam, J, et al.
Publicado: (2015)

Anakinra for patients with COVID-19
por: Martin-Silva, Nicolas, et al.
Publicado: (2020)

Systemic autoinflammatory disorders: autoinflammatory and autoimmune disorders
por: Kim, Young Dae
Publicado: (2023)

The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases
por: Gaggiano, Carla, et al.
Publicado: (2022)

Curation and expansion of the Human Phenotype Ontology for systemic autoinflammatory diseases improves phenotype-driven disease-matching
por: Maassen, Willem, et al.
Publicado: (2023)

Human Autoinflammatory Diseases Mediated by NLRP3-, Pyrin-, NLRP1-, and NLRC4-Inflammasome Dysregulation Updates on Diagnosis, Treatment, and the Respective Roles of IL-1 and IL-18
por: Alehashemi, Sara, et al.
Publicado: (2020)

Inbreeding and pedigree analysis of the European red dairy cattle
por: Nyman, Sofia, et al.
Publicado: (2022)

The effect of Anakinra on Quality-of-Life in a family with colchicine-resistant FMF
por: van der Hilst, J, et al.
Publicado: (2015)

PW02-034 - NLRP3 mosaicism detection in CAPS using NGS
por: Stoffels, M, et al.
Publicado: (2013)

Effect of anakinra in COVID-19
por: Kooistra, Emma J, et al.
Publicado: (2020)

Dysfunctional BLK in common variable immunodeficiency perturbs B-cell proliferation and ability to elicit antigen-specific CD4(+) T-cell help
por: Compeer, Ewoud B., et al.
Publicado: (2015)

Anakinra in children and adults with Still’s disease
por: Vastert, Sebastiaan J, et al.
Publicado: (2019)

Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases
por: Correa, Ricardo G., et al.
Publicado: (2012)

The Eurofever Registry for autoinflammatory diseases: results of the first 15 months of enrolment
por: Toplak, N, et al.
Publicado: (2011)

Continuous IV infusion of anakinra
por: Saunders, Brittney N., et al.
Publicado: (2023)

Therapy of autoinflammatory diseases: results from an international registry
por: ter Haar, NM, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9l8fh227pe8ufn9l3u8jph2pr6